Q-omics provides the consensus-scored SOX10 profile across patient tissues and cancer cell-line models. Additionally, SOX10 RNA expression shows 15,564 significant protein co-abundance associations, with the highest sampling consensus in GBM.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for SOX10 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with SOX10 in patient tissues and cancer cell lines. In patient samples, SOX10 shows the broadest associations at the RNA and protein expression levels, with GBM recurring as the lineage with the largest associated feature set. In cancer cell lines, SOX10 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in SKIN, while CRISPR and shRNA rows add functional-dependency signals in BLOOD_Leukemia and BLOOD_Myeloma.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Protein (mass-spec)	15,564	GBM (7491)	view →
Function (mass-spec)	1,388	GBM (804)	view →
▼Protein (mass-spec)
Protein (mass-spec)	9,856	GBM (5291)	view →
RNA	5,944	BRCA (2393)	view →
▼Mutation
RNA	1,126	UCEC (906)	view →
Protein (RPPA)	7	UCEC (5)	view →

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼CRISPR
RNA	3,414	SKIN (2262)	view →
CRISPR	2,194	SKIN (423)	view →
▼RNA
RNA	8,624	BLOOD_Leukemia (4029)	view →
Function (RNA)	3,260	SKIN (1037)	view →
▼shRNA
shRNA	2,049	BLOOD_Myeloma (343)	view →
RNA	1,716	BLOOD_Leukemia (286)	view →
▼Mutation
Mutation	288	BLOOD_Leukemia (146)	view →
RNA	5	BLOOD_Leukemia (5)	view →